Jay P. Shepard
Jay Shepard joined our board of directors in December 2020. Mr. Shepard is an advisor at Caralys Pacific, a venture group focused on licensing drug programs and creating new companies in the U.S. and Japan. Mr. Shepard previously was president and chief executive officer of Aravive, Inc. (formerly Versartis, Inc.), a clinical-stage oncology company, from […]
Catherine Moukheibir
Catherine Moukheibir joined our board of directors in April 2019. Ms. Moukheibir most recently served as chief executive officer of MedDay Pharmaceuticals, or MedDay, a biopharmaceutical company that focused on nervous system disorders, from July 2019 to January 2021. She was also the chair of the board of directors of MedDay from April 2016 to January 2021. Prior to that, […]
Thomas McCourt
Tom McCourt joined Ironwood in 2009 as senior vice president of marketing and sales and chief commercial officer, advancing to hold the roles of president and interim chief executive officer before becoming chief executive officer and member of the board of directors in 2021. He has played an instrumental role in the success of the […]
Marla Kessler
Marla Kessler joined our board of directors in April 2019. Ms. Kessler most recently served as chief marketing officer of Datavant, Inc., or Datavant, a health IT company, from October 2022 to April 2024. Prior to joining Datavant, Ms. Kessler served as chief customer officer of Aetion, Inc., or Aetion, a health care technology company, […]
Jon Duane
Jon Duane joined our board of directors in April 2019. Mr. Duane is senior partner emeritus at McKinsey & Company, or McKinsey, an international management consulting company. Before his retirement in December 2017, Mr. Duane had served as a partner at McKinsey since 1992. At McKinsey, Mr. Duane founded and led the firm’s biotech practice. […]
Alexander Denner, Ph.D.
Alexander Denner joined our board of directors in October 2020. Dr. Denner is a founding partner and the chief investment officer of Sarissa Capital Management LP, or Sarissa, a registered investment advisor, where he has been since 2011. Prior to joining Sarissa, Dr. Denner served as a senior managing director at Icahn Capital LP, an […]
Julie McHugh
Julie McHugh joined our board of directors in February 2014 and became chair of our board in April 2019. Ms. McHugh most recently served as chief operating officer for Endo Health Solutions, Inc., or Endo, from 2010 through 2013, where she was responsible for the specialty pharmaceutical and generic drug businesses. Prior to joining Endo, […]
Mark Currie, Ph.D.
Mark Currie joined our board of directors in April 2019. Dr. Currie has been a partner of Iaso Ventures, LP, an early-stage healthcare venture capital firm, since January 2024. Dr. Currie was previously the chair of the scientific advisory board of Cyclerion Therapeutics, Inc., or Cyclerion, a clinical-stage biopharmaceutical company, from January 2021 to September […]